Shenzhou Cell (688520.SH): The registration certificate for the injection of Fennel Monoclonal Antibody has been obtained.

date
16:02 11/02/2025
avatar
GMT Eight
Shenzhou Cell (688520.SH) issued an announcement, the company's holding subsidiary Shenzhou Cell Engineering Co., Ltd. (referred to as "
Shenzhou Cell (688520.SH) announced that its holding subsidiary Shenzhou Cell Engineering Co., Ltd. recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the approval of the injection of panitumumab (trade name: Anyouping), used in the treatment of head and neck squamous cell carcinoma.